d-Methionine provides excellent protection from cisplatin ototoxicity in the rat
Authors:
- Kathleen C.M. CampbellKCKathleen C.M. Campbell
- Leonard P. RybakLRLeonard P. Rybak
- Robert P. MeechRMRobert P. Meech
- Larry HughesLHLarry Hughes
- 1 December 1996
- journal article
- research article
- Published by Elsevier in Hearing Research
- Vol. 102 (1-2) , 90-98
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicityHearing Research, 1995
- The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3+-pretreatment in the rat in vivo and in vitroBiochemical Pharmacology, 1991
- Protection against cisplatin toxicity by administration of glutathione ester 1The FASEB Journal, 1990
- Some procedures to reduce cis-platinum toxicity reduce antitumour activityCancer Treatment Reviews, 1987
- Cisplatin: Evaluation of its ototoxic potentialAmerican Journal of Otolaryngology, 1986
- High-dose cisplatin in patients with advanced malignanciesCancer, 1985
- Early detection of cisplatin ototoxicity selected case reportsCancer, 1984
- Exacerbation of cisplatin-induced nephrotoxicity by methionineChemico-Biological Interactions, 1984
- Cis‐Diamminedichloroplatinum (II) Ototoxicity in the Guinea PigOtolaryngology–Head and Neck Surgery, 1981
- Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patientsJournal of Surgical Oncology, 1981